Jacobs Levy Equity Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-861,801
| Closed | -$9.53M | – | 1096 |
|
|
2023
Q2 | $9.53M | Sell |
861,801
-61,568
| -7% | -$681K | 0.05% | 283 |
|
|
2023
Q1 | $12.4M | Buy |
923,369
+262
| +0% | +$3.52K | 0.08% | 253 |
|
|
2022
Q4 | $11.4M | Buy |
923,107
+142,162
| +18% | +$1.76M | 0.08% | 263 |
|
|
2022
Q3 | $10.9M | Buy |
780,945
+135,254
| +21% | +$1.89M | 0.09% | 246 |
|
|
2022
Q2 | $8.92M | Buy |
645,691
+53,387
| +9% | +$737K | 0.07% | 300 |
|
|
2022
Q1 | $9.64M | Buy |
592,304
+3,382
| +0.6% | +$55K | 0.06% | 299 |
|
|
2021
Q4 | $9.59M | Buy |
588,922
+54,746
| +10% | +$892K | 0.06% | 309 |
|
|
2021
Q3 | $7.93M | Sell |
534,176
-79,712
| -13% | -$1.18M | 0.05% | 349 |
|
|
2021
Q2 | $12.3M | Buy |
613,888
+81,786
| +15% | +$1.63M | 0.08% | 255 |
|
|
2021
Q1 | $12.3M | Buy |
532,102
+52,378
| +11% | +$1.21M | 0.09% | 248 |
|
|
2020
Q4 | $11.8M | Buy |
479,724
+132,478
| +38% | +$3.27M | 0.1% | 226 |
|
|
2020
Q3 | $14.4M | Buy |
347,246
+297,789
| +602% | +$12.3M | 0.15% | 156 |
|
|
2020
Q2 | $2.37M | Buy |
49,457
+5,455
| +12% | +$261K | 0.03% | 495 |
|
|
2020
Q1 | $2.77M | Sell |
44,002
-340
| -0.8% | -$21.4K | 0.04% | 416 |
|
|
2019
Q4 | $5.5M | Buy |
44,342
+4,050
| +10% | +$502K | 0.05% | 351 |
|
|
2019
Q3 | $2.67M | Buy |
+40,292
| New | +$2.67M | 0.03% | 454 |
|
|
2016
Q3 | – | Sell |
-8,120
| Closed | -$1.16M | – | 1159 |
|
|
2016
Q2 | $1.16M | Sell |
8,120
-4,920
| -38% | -$702K | 0.02% | 545 |
|
|
2016
Q1 | $1.68M | Buy |
+13,040
| New | +$1.68M | 0.04% | 450 |
|